Reneo Pharmaceuticals launches REN001 clinical trial in McArdle disease

Reneo Pharmaceuticals has initiated a phase 1b clinical trial of REN001 in glycogen storage disease type V (GSD V), also called McArdle disease. The California-based ... Read More